Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns
Andrea Galassi(University of Milan), Mario Cozzolino(AOL (United States)), Federico Maffei Faccioli(University of Milan), Anila Cara(University of Milan), Lorenza Magagnoli(AOL (United States))
Cited by 2
Related Papers
37th International Symposium on Intensive Care and Emergency Medicine (part 2 of 3)
|Critical Care|2017|61
Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study
|Clinical Kidney Journal|2019|50
Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
|Nephrology Dialysis Transplantation|2023|37
Choice of the Dialysis Modality: Practical Considerations
|Journal of Clinical Medicine|2023|30
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs
|Expert Opinion on Investigational Drugs|2024|24